Literature DB >> 7482723

Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells.

M Senda1, B DeLustro, E Eugui, Y Natsumeda.   

Abstract

Mycophenolic acid (MPA), an inhibitor of IMP dehydrogenase and de novo GTP biosynthesis, also has immunosuppressive activity. The effect of MPA on nitric oxide (NO) production by rodent brain vascular endothelial cells in culture was investigated. MPA inhibited NO production by mouse and rat brain endothelial cells that had been stimulated with a combination of interferon-gamma and tumor necrosis factor-alpha. The 50% inhibitory concentration (EC50) was in the range of 0.5-1.0 microM. However, MPA had no effect on basal NO production in mouse brain vascular endothelial cells. Brequinar, an inhibitor of de novo pyrimidine synthesis, had no effect on NO production in cytokine stimulated endothelial cells. Guanosine, which can act as a salvage pathway precursor for GTP biosynthesis, reversed the inhibitory effect of MPA in a dose-dependent fashion. We suggest that inducible NO synthase activity is dependent on GTP level and can be blocked by curtailing IMP dehydrogenase activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7482723     DOI: 10.1097/00007890-199511270-00015

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.

Authors:  Tim Ulinski; Laurence Dubourg; Marie Hélène Saïd; Bernadette Parchoux; Bruno Ranchin; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2005-02-18       Impact factor: 3.714

2.  Reversal of TNP-470-induced endothelial cell growth arrest by guanine and guanine nucleosides.

Authors:  John Hines; Rong Ju; Ginger E Dutschman; Yung-Chi Cheng; Craig M Crews
Journal:  J Pharmacol Exp Ther       Date:  2010-06-22       Impact factor: 4.030

3.  Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil.

Authors:  D Maksimovic-Ivanic; V Trajkovic; D J Miljkovic; M Mostarica Stojkovic; S Stosic-Grujicic
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

4.  Brain dead donor kidneys are immunologically active: is intervention justified?

Authors:  G Vergoulas; P Boura; G Efstathiadis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

5.  BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway.

Authors:  Y Liu; T Yang; H Li; M-H Li; J Liu; Y-T Wang; S-X Yang; J Zheng; X-Y Luo; Y Lai; P Yang; L-M Li; Q Zou
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  Mycophenolic acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts.

Authors:  Dj Miljkovic; I Cvetkovic; S Stosic-Grujicic; V Trajkovic
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

7.  Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE.

Authors:  Maureen McMahon; Brian Skaggs; Jennifer Grossman; Weng Kee Wong; Lori Sahakian; Weiling Chen; Bevra Hahn
Journal:  Lupus Sci Med       Date:  2019-06-27

8.  Bioactivity-Guided Isolation and Identification of New and Immunosuppressive Monoterpenoid Indole Alkaloids from Rauvolfia yunnanensis Tsiang.

Authors:  Li-Mei Li; Shun-Dong Shi; Yang Liu; Qiang Zou
Journal:  Molecules       Date:  2019-12-13       Impact factor: 4.411

Review 9.  New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid.

Authors:  Da-Wei Lin; Cheng-Chih Chang; Yung-Chien Hsu; Chun-Liang Lin
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

10.  Mycophenolate mofetil in the treatment of lupus nephritis.

Authors:  Patrick Fk Yong; David P D'Cruz
Journal:  Biologics       Date:  2008-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.